[Prolactin in pathology of the breast. Clinical study]
- PMID: 7393472
[Prolactin in pathology of the breast. Clinical study]
Abstract
In the last years many Authors on the grounds of clinical and experimental studies have assumed the possibility of a connection between the prolactin and the breast pathology especially the carcionoma. In the present work the Authors give the results of the doses of the prolactin plasmatic basal levels, performed on 122 subjects belonging to 4 different groups: 1) patients with carcinoma of the breast; 2) patients with benign tumors of the breast; 3) patients with fibrocystic breast disease; 4) subjects of control. In patients who have undergone an operation further doses of blood prolactin have been carried out on 5th, 10th, 30th day after operation. On the grounds of such results the Authors propose new hypothesis of work wich will help to clear this problem.
Similar articles
-
[Prolactin--significance in benign and malignant breast diseases].Z Lymphol. 1988 Jul;12(1):30-5. Z Lymphol. 1988. PMID: 3051756 Review. German.
-
Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.Clin Oncol. 1981 Sep;7(3):213-9. Clin Oncol. 1981. PMID: 6211319 No abstract available.
-
[Metoclopramide stimulation in patients with benign breast disease (author's transl)].Rev Med Chil. 1979 Aug;107(8):733-6. Rev Med Chil. 1979. PMID: 545567 Spanish. No abstract available.
-
[Dosage of prolactin in normal and pathological subjects (author's transl)].Ann Endocrinol (Paris). 1976 May-Jun;37(3):127-56. Ann Endocrinol (Paris). 1976. PMID: 828474 French.
-
Prolactin and breast carcinoma.N Engl J Med. 1975 Apr 10;292(15):784-92. doi: 10.1056/NEJM197504102921506. N Engl J Med. 1975. PMID: 1089886 Review.
Cited by
-
Epidemiology and endocrinology of benign breast disease.Breast Cancer Res Treat. 1985;6(1):5-36. doi: 10.1007/BF01806008. Breast Cancer Res Treat. 1985. PMID: 3902125 Review.
MeSH terms
Substances
LinkOut - more resources
Medical